Inotiv, Inc. (NOTV)
Pre-market:
| Previous close | 3.7400 |
| Open | 3.8100 |
| Bid | 3.8000 x 400 |
| Ask | 3.8800 x 400 |
| Day's range | 3.6350 - 3.9900 |
| 52-week range | 1.6100 - 11.4200 |
| Volume | |
| Avg. volume | 499,255 |
| Market cap | 99.036M |
| Beta (5Y monthly) | 3.20 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.2900 |
| Earnings date | 10 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 15.50 |
GlobeNewswireInotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Friday, May 10, 2024
WEST LAFAYETTE, Ind., April 29, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it will issue its financial results for the fiscal 2024 second quarter ended March 31, 2024, on Friday, May 10, 2024, before the opening of the stock market. The Company will host a con
ZacksInotiv (NOTV) Is a Great Choice for 'Trend' Investors, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Inotiv (NOTV) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
ZacksWhy Fast-paced Mover Inotiv (NOTV) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Inotiv (NOTV) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
